Cargando…

Insights Into Development and Progression of Idiopathic Pulmonary Fibrosis From Single Cell RNA Studies

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited therapeutic options. The current model suggests that chronic or repetitive “micro-injuries” of the alveolar epithelium lead to activation and proliferation of fibroblasts and excessive extracellular matrix (ECM)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nemeth, Julia, Schundner, Annika, Frick, Manfred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772461/ https://www.ncbi.nlm.nih.gov/pubmed/33392232 http://dx.doi.org/10.3389/fmed.2020.611728

Ejemplares similares

A Novel Fibroblast Reporter Cell Line for in vitro Studies of Pulmonary Fibrosis
por: Nemeth, Julia, et al.
Publicado: (2020)

In Vitro Measurements of Cellular Forces and their Importance in the Lung—From the Sub- to the Multicellular Scale
por: Kolb, Peter, et al.
Publicado: (2021)

Inflammatory Leukocyte Phenotypes Correlate with Disease Progression in Idiopathic Pulmonary Fibrosis
por: Moore, Bethany B., et al.
Publicado: (2014)

Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study
por: Leuschner, Gabriela, et al.
Publicado: (2020)

The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
por: Desai, Omkar, et al.
Publicado: (2018)

The Management of Patients With Idiopathic Pulmonary Fibrosis
por: Spagnolo, Paolo, et al.
Publicado: (2018)

Telomere Dysfunction in Idiopathic Pulmonary Fibrosis
por: Zhang, Kexiong, et al.
Publicado: (2021)

Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
por: Takei, Reoto, et al.
Publicado: (2023)

Treatment of Idiopathic Pulmonary Fibrosis
por: Abuserewa, Sherif T, et al.
Publicado: (2021)

Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
por: Kaur, Amarpreet, et al.
Publicado: (2017)

Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis
por: Tashiro, Jun, et al.
Publicado: (2017)

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
por: Oldham, Justin M., et al.
Publicado: (2017)

Editorial: Idiopathic pulmonary fibrosis: epidemiology, prognosis and treatment
por: Caminati, Antonella, et al.
Publicado: (2023)

Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
por: Zank, Daniel C., et al.
Publicado: (2018)

Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis
por: Moor, Catharina C., et al.
Publicado: (2017)

Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
por: Tzilas, Vasilios, et al.
Publicado: (2017)

Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?
por: Sesé, Lucile, et al.
Publicado: (2021)

Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine
por: Alonso-Gonzalez, Aitana, et al.
Publicado: (2023)

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
por: Lancaster, Lisa, et al.
Publicado: (2020)

Dyspnoea with progressive “idiopathic” pulmonary fibrosis
por: Puri, Chahat, et al.
Publicado: (2021)

Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2017)

Lung Tissue Microbiome Is Associated With Clinical Outcomes of Idiopathic Pulmonary Fibrosis
por: Yoon, Hee-Young, et al.
Publicado: (2021)

Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics
por: Cottin, Vincent, et al.
Publicado: (2021)

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies
por: Guo, Hehua, et al.
Publicado: (2023)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Microscopic polyangiitis initially presenting with idiopathic pulmonary fibrosis: a case report
por: Shao, Chi, et al.
Publicado: (2023)

Non-coding RNAs as Regulators of Cellular Senescence in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
por: Omote, Norihito, et al.
Publicado: (2020)

Single-Cell RNA Sequencing Provides New Insights into Therapeutic Roles of Thyroid Hormone in Idiopathic Pulmonary Fibrosis
por: Wang, Lan, et al.
Publicado: (2023)

Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis
por: Unterman, Avraham, et al.
Publicado: (2023)

Clinical relevance of circulating autoantibodies in idiopathic pulmonary fibrosis; A NAt hard to break
por: Kirgou, Paraskevi, et al.
Publicado: (2022)

Road Toward a New Model of Care for Idiopathic Pulmonary Fibrosis in the Lazio Region
por: Di Bidino, Rossella, et al.
Publicado: (2022)

Mendelian randomization study reveals the effect of idiopathic pulmonary fibrosis on the risk of erectile dysfunction
por: Zhang, Kun, et al.
Publicado: (2023)

Real world experience on the effectiveness and safety of pirfenidone in patients with idiopathic pulmonary fibrosis in Taiwan
por: Chang, Cheng-Yu, et al.
Publicado: (2023)

Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World
por: Polke, Markus, et al.
Publicado: (2021)

A Micro RNA Processing Defect in Rapidly Progressing Idiopathic Pulmonary Fibrosis
por: Oak, Sameer R., et al.
Publicado: (2011)

Overwhelming COVID-19 Sepsis in a Patient With Idiopathic Pulmonary Fibrosis
por: Akram, Ayesha
Publicado: (2020)

Pulmonary nocardiosis following COVID-19 in a patient with idiopathic pulmonary fibrosis and lung transplantation: a case report
por: Cao, Liming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bl151fdnqkbhgkmdrlbsjo8f2a